Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone + naloxone versus methadone for opioid dependence
ACTRN12621000899842Phase 2Not yet recruiting
- Sponsor
- Western Sydney Local Health District Drug Health
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methadone + naloxone and methadone in opioid use disorder (OUD) (2 arms), sponsored by Western Sydney Local Health District Drug Health. Primary endpoint: Change in drug injection behaviour. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
methadone + naloxonemethadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on ACTRN12621000899842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000899842.